NMPA Approval

Mitoxantrone Hydrochloride for Injection

Approval Number

国药准字H20060894

Company江苏奥赛康药业有限公司

Registration Date

January 14, 2021

Previous Approval Numbers

国药准字H20060894

Drug Information

Generic Name

注射用盐酸米托蒽醌

Brand Name

奥麦

Dosage Form

注射剂

Strength

5mg(按C22H28N4O6计)

Drug Type

化学药品

Registration Date

January 14, 2021

Company Information

Applicant Company

Company Name江苏奥赛康药业有限公司

Company Address

南京江宁科学园科建路699号

Manufacturing Company

Company Name江苏奥赛康药业有限公司

Company Address

南京江宁科学园科建路699号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸米托蒽醌 - NMPA 批准文号 | MedPath